Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: Be aware of atropinic and benzodiazepine drugs!

European Journal of Clinical Pharmacology

Volumn 69, Issue 8, 2013, Pages 1589-1597

  Montastruc, François ^a,b   Gardette, Virginie ^a,b,c   Cantet, Christelle ^b,c   Piau, Antoine ^d   Lapeyre Mestre, Maryse ^a,b,c   Vellas, Bruno ^c,d   Montastruc, Jean Louis ^a,b,c   Andrieu, Sandrine ^a,b,c  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c CNRS   (France)

^d CHU PURPAN   (France)

Author keywords

Alzheimer's disease; Atropinic drugs; Benzodiazepines; Potentially inappropriate medications

Indexed keywords

BENZODIAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR;

AGED; ALZHEIMER DISEASE; ARTICLE; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DRUG USE; EDUCATIONAL STATUS; FEMALE; HUMAN; INAPPROPRIATE PRESCRIBING; INCOME; MAJOR CLINICAL STUDY; MALE; POLYPHARMACY; POTENTIALLY INAPPROPRIATE MEDICATION; PRIORITY JOURNAL; SEX DIFFERENCE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATROPINE DERIVATIVES; BENZODIAZEPINES; COHORT STUDIES; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; LOGISTIC MODELS; MALE; POLYPHARMACY; PREVALENCE; PROSPECTIVE STUDIES;

EID: 84880506710     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-013-1506-8     Document Type: Article

References (44)

1. Viktil KK, Blix HS, Moger TA, Reikvam A (2007) Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 63:187-195
2. Agence de Sécurité Sanitaire des Produits de Santé (Afssaps) and Réseau Français des Centres Régionaux de Pharmacovigilance (AFCRPV) Etude PEIMA (2011) Prévalence des effets indésirables médicamenteux chez les patients atteints de la maladie d'Alzheimer ou d'un syndrome démentiels. Available at: http://www.chu-montpellier.fr/publication/inter-pub/R361/A7610/ RapportPEIMAfinal.pdf
3. Onder G, Gambassi G, Scales CJ, Cesari M, Vedova CD, Landi F, Bernabei R (2002) Adverse drug reactions and cognitive function among hospitalized older adults. Eur J Clin Pharmacol 58:371-377
4. Ganjavi H, Herrmann N, Rochon PA, Sharma P, Lee M, Cassel D et al (2007) Adverse drug events in cognitively impaired elderly patients. Dement Geriatr Cogn Disord 23:395-400
5. Chang CB, Chen JH, Wen CJ, Kuo HK, Lu IS, Chiu LS, Wu SC, Chan DC (2011) Potentially inappropriate medications in geriatric outpatients with polypharmacy: application of six sets of published explicit criteria. Br J Clin Pharmacol 72:482-489
6. Beers MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 157:1531-1536
7. Laroche ML, Charmes JP, Merle L (2007) Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 63:725-731
8. Holmes HM, Sachs GA, Shega JW, Hougham GW, Cox Hayley D, Dale W (2008) Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use. J Am Geriatr Soc 56:1306-1311
9. Lau DT, Mercaldo ND, Harris AT, Trittschuh E, Shega J, Weintraub S (2010) Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia. Alzheimer Dis Assoc Disord 24:56-63
10. Zuckerman IH, Hernandez JJ, Gruber-Baldini AL, Hebel JR, Stuart B, Zimmerman S, Magaziner J (2005) Potentially inappropriate prescribing before and after nursing home admission among patients with and without dementia. Am J Geriatr Pharmacother 3:246-254
11. Fick D, Kolanowski A, Waller J (2007) High prevalence of central nervous system medications in community-dwelling older adults with dementia over a three-year period. Aging Ment Health 11:588-595
12. Gillette-Guyonnet S, Nourhashemi F, Andrieu S, Cantet C, Micas M, Ousset PJ, Vellas B, REAL.FR Group (2003) The REAL.FR research program on Alzheimer's disease and its management: methods and preliminary results. J Nutr Health Aging 7:91-96
13. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The index of ADL: a standardized measure of biological and phychosocial function. JAMA 185:914-919
14. Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9:179-186
15. Rosen WG, Mohs RC, Davis KL (1984) A new rating scale for Alzheimer's disease. Am J Psychiatry 141:1356-1364
16. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566-572
17. Vellas B, Guigoz Y, Garry PJ, Nourhashemi F, Bennahum D, Lauque S, Albarede JL (1999) The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 15:116-122
18. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308-2314
19. Zarit SH, Reever KE, Bach-Peterson J (1980) Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist 20:649-655
20. WHO Collaborating Centre for Drug Statistics Methodology. Available at: http://www.whocc.no/atcddd/
21. Jyrkkä J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S (2009) Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging 26:1039-1048
22. Onder G, Liperoti R, Fialova D, Topinkova E, Tosato M, Danese P, Gallo PF, Carpenter I, Finne-Soveri H, Gindin J, Bernabei R, Landi F, SHELTER Project (2012) Polypharmacy in nursing home in Europe: results from the SHELTER study. J Gerontol A Biol Sci Med Sci 67:698-704
23. Rédaction Prescrire (2001) Eviter les effets indésirables par interactions medicamenteuses: comprendre et décider. Rev Prescr 31:416
24. Boustani MA, Campbell NL, Munger S, Maidment I, Fox GC (2008) Impact of anticholinergics on the aging brain: a review and practical application. Aging Health 4:311-320
25. Campbell N, Boustani M, Limbil T, Ott C et al (2009) The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging 4:225-233
26. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH (2003) Updating the beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163:2716-2724
27. StataCorp (2009) Stata statistical software: Release 11. StataCorp LP, College Station
28. Colloca G, Tosato M, Vetrano DL, Topinkova E, Fialova D, Gindin J, van der Roest HG, Landi F, Liperoti R, Bernabei R, Onder G, SHELTER project (2012) Inappropriate drugs in elderly patients with severe cognitive impairment: results from the shelter study. PLoS One 7:e46669
29. Laroche ML, Charmes JP, Bouthier F, Merle L (2009) Inappropriate medications in the elderly. Clin Pharmacol Ther 85:94-97
30. Bongue B, Naudin F, Laroche ML, Galteau MM, Guy C, Guéguen R, Convers JP, Colvez A, Maarouf N (2009) Trends of the potentially inappropriate medication consumption over 10 years in older adults in the East of France. Pharmacoepidemiol Drug Saf 18:1125-1133
31. Laroche ML, Charmes JP, Nouaille Y, Fourrier A, Merle L (2006) Impact of hospitalization in an acute medical geriatric unit on potentially inappropriate medication use. Drugs Aging 23:49-59
32. Bouvenot G (1999) Consumption and prescription of "cerebral vasodilators" in community AFSSAPS Saint Denis. Available at: http://www.afssaps.fr/var/afssaps-site/storage/original/application/ 5f7c8b4942b1fc927ad7d2b11f13ddf7.pdf
33. Nagaraja D, Jayashree S (2001) Randomized study of the dopamine receptor agonist piribedil in the treatment of mild cognitive impairment. Am J Psychiatry 158:1517-1519
34. Tavassoli N, Sommet A, Lapeyre-Mestre MP, Bagheri H, Montrastruc JL (2007) Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formulary (Vidal, British National Formulary). Drug Saf 30:1063-1071
35. Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D, Coulton S, Katona C, Boustani MA, Brayne C (2011) Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc 59:1477-1483
36. Wu CS, Ting TT, Wang SC, Chang IS, Lin KM (2011) Effect of benzodiazepine discontinuation on dementia risk. Am J Geriatr Psychiatry 19:151-159
37. Boeuf-Cazou O, Bongue B, Ansiau D, Marquié JC, Lapeyre-Mestre M (2011) Impact of long-term benzodiazepine use on cognitive functioning in young adults: the VISAT cohort. Eur J Clin Pharmacol 67:1045-1052
38. Billioti de Gage S, Bégaud B, Bazin F, Verdoux H, Dartigues JF, Pérès K, Kurth T, Pariente A (2012) Benzodiazepine use and risk of dementia: prospective population based study. Br Med J 345:e6231. doi: 10.1136/bmj.e6231
39. Özdemir V, Fourie J, Busto U, Naranjo CA (1996) Pharmacokinetic changes in the elderly: do they contribute to drug abuse and dependence? Clin Pharmacokinet 31:372-385
40. Ruggiero C, Dell'Aquila G, Gasperini B, Onder G, Lattanzio F, Volpato S, Corsonello A, Maraldi C, Bernabei R, Cherubini A, ULISSE Study Group (2010) Potentially inappropriate drug prescriptions and risk of hospitalization among older, Italian, nursing home residents: the ULISSE project. Drugs Aging 27:747-758
41. Weston AL, Weinstein AM, Barton C, Yaffe K (2010) Potentially inappropriate medication use in older adults with mild cognitive impairment. J Gerontol A Biol Sci Med Sci 65:318-321
42. Lapeyre-Mestre M, Chastan E, Louis A, Montastruc JL (1999) Drug consumption in workers in France: a comparative study at a 10-year interval (1996 versus 1986). J Clin Epidemiol 52:471-478
43. Fialová D, Topinková E, Gambassi G, Finne-Soveri H, Jónsson PV, Carpenter I, Schroll M, Onder G, Sørbye LW, Wagner C, Reissigová J, Bernabei R, AdHOC Project Research Group (2005) Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 293:1348-1358
44. Reynish E, Cortes F, Andrieu S, Cantet C, Olde Rikkert M, Melis R, Froelich L, Frisoni GB, Jönsson L, Visser PJ, Ousset PJ, Vellas B, ICTUS Study Group (2007) The ICTUS Study: a prospective longitudinal observational study of 1,380 AD patients in Europe. Study design and baseline characteristics of the cohort. Neuroepidemiology 29:29-38